share_log

JMP Securities Maintains Market Outperform on Aura Biosciences, Lowers Price Target to $19

JMP Securities Maintains Market Outperform on Aura Biosciences, Lowers Price Target to $19

JMP Securities维持Aura Biosciences的市场跑赢大盘,将目标股价下调至19美元
Benzinga ·  2023/11/10 14:40

JMP Securities analyst Jonathan Wolleben maintains Aura Biosciences (NASDAQ:AURA) with a Market Outperform and lowers the price target from $21 to $19.

JMP Securities分析师乔纳森·沃勒本维持Aura Biosciences(纳斯达克股票代码:AURA)的市场跑赢大盘,并将目标股价从21美元下调至19美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发